Those Bio-A cash figures were largely influenced by payment cycle of distributor (I rang to query them)
I don't see Bio-A in Australia being significant for SLA, for some time if at all.
Bio-A will only become significant (imo) if they can get it into some international health programmes eg for H.Porlori or for MRSA in hospitals.
- Forums
- ASX - By Stock
- SLA
- trials: no further need at the moment
trials: no further need at the moment, page-30
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)